FDA Approves Single REMS for Mycophenolate Class of Drugs

Article

FDA approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for all mycophenolate-containing prescription drugs at the end of September.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
Q&A: Support, Reimbursement Key For Expanded Pharmacy Services | PQA 2025

Q&A: Support, Reimbursement Key For Expanded Pharmacy Services | PQA 2025

Killian Meara;Michael Hegener, PharmD, BCACP
August 15th 2025
Article
The Current, Future Roles of AI within the Pharmacy Profession

The Current, Future Roles of AI within the Pharmacy Profession

Brian Nowosielski;Scott Nelson, PharmD, MS, FAMIA, ACHIP
August 15th 2025
Podcast
Q&A: Pharmacists Bridge the Gap in Safe Medication Disposal | PQA 2025

Q&A: Pharmacists Bridge the Gap in Safe Medication Disposal | PQA 2025

Killian Meara;Mitchell Barnett, PharmD, MS
August 15th 2025
Article
The Unique Challenges, Growth in the Business of Health-System Pharmacy

The Unique Challenges, Growth in the Business of Health-System Pharmacy

Brian Nowosielski;Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST
August 15th 2025
Podcast
Pharmacists’ Role in Addressing Vaccine Barriers Among Underserved Communities | APhA 2025

Pharmacists’ Role in Addressing Vaccine Barriers Among Underserved Communities | APhA 2025

Brian Nowosielski
August 15th 2025
Article
Q&A: What Role Will Pharmacists Play in Precision Medicine?

Q&A: What Role Will Pharmacists Play in Precision Medicine?

Killian Meara;George Van Antwerp, MBA
August 15th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.